Bessemer Group Inc Xencor Inc Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Bessemer Group Inc holds 39 shares of XNCR stock, worth $413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 130
70.0%
Holding current value
$413
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XNCR
# of Institutions
200Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$118 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$95.2 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$85 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$65.1 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$42.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $633M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...